Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Agnès Bloch-Zupan is active.

Publication


Featured researches published by Agnès Bloch-Zupan.


Human Mutation | 2010

Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome

Vincent Laugel; Cecile Dalloz; Myriam Durand; Florence Sauvanaud; Hans-Ulrik Kristensen; Marie-Claire Vincent; Laurent Pasquier; Sylvie Odent; Valérie Cormier-Daire; Blanca Gener; Edward S. Tobias; John Tolmie; Dominique Martin-Coignard; Valérie Drouin-Garraud; Delphine Héron; Hubert Journel; Emmanuel Raffo; Jaqueline Vigneron; Stanislas Lyonnet; Victoria Murday; Danielle Gubser-Mercati; Benoît Funalot; Louise Brueton; Jaime Sanchez del Pozo; E. Muñoz; Andrew R. Gennery; Mustafa A. Salih; Mehrdad Noruzinia; K. Prescott; L. Ramos

Cockayne syndrome is an autosomal recessive multisystem disorder characterized principally by neurological and sensory impairment, cachectic dwarfism, and photosensitivity. This rare disease is linked to mutations in the CSB/ERCC6 and CSA/ERCC8 genes encoding proteins involved in the transcription‐coupled DNA repair pathway. The clinical spectrum of Cockayne syndrome encompasses a wide range of severity from severe prenatal forms to mild and late‐onset presentations. We have reviewed the 45 published mutations in CSA and CSB to date and we report 43 new mutations in these genes together with the corresponding clinical data. Among the 84 reported kindreds, 52 (62%) have mutations in the CSB gene. Many types of mutations are scattered along the whole coding sequence of both genes, but clusters of missense mutations can be recognized and highlight the role of particular motifs in the proteins. Genotype–phenotype correlation hypotheses are considered with regard to these new molecular and clinical data. Additional cases of molecular prenatal diagnosis are reported and the strategy for prenatal testing is discussed. Two web‐based locus‐specific databases have been created to list all identified variants and to allow the inclusion of future reports (www.umd.be/CSA/ and www.umd.be/CSB/). Hum Mutat 31:113–126, 2010.


Orphanet Journal of Rare Diseases | 2009

Orodental phenotype and genotype findings in all subtypes of hypophosphatasia

Amélie Reibel; Marie-Cécile Manière; François Clauss; Dominique Droz; Yves Alembik; Etienne Mornet; Agnès Bloch-Zupan

BackgroundHypophosphatasia (HP) is a rare inherited disorder characterized by a wide spectrum of defects in mineralized tissues and caused by deficiency in the tissue non-specific alkaline phosphatase gene (ALPL). The symptoms are highly variable in their clinical expression, and relate to numerous mutations in this gene. The first clinical sign of the disease is often a premature loss of deciduous teeth, mostly in the moderate forms.AimThe purpose of this study was to document the oral features of HP patients and to relate theses features to the six recognized forms of HP in 5 patients with known genotype and to investigate the genotype-phenotype correlations.MethodsClinical and radiographic examinations were carried out. We collected medical and dental history in the kindred and biochemical data. Finally, mutations in the ALPL gene were tested by DNA sequencing in SESEP laboratory.ResultsWe have for the first time related the known dental anomalies which occur as integral features of HP to the recognized clinical forms of HP. We also pointed out striking dental abnormalities which were never described in association with this rare disease. Accurate genotype-phenotype severity correlations were observed.ConclusionThis work allowed us to compare orodental manifestations in all the clinical forms of HP within the patients sample. According to the severity of the disorder, some dental defects were infrequent, while other were always present. The long term prognosis of the permanent teeth varies from a patient to another. As premature loss of primary teeth is often the first, and sometimes the only visible symptom of the milder forms, the paediatric dentist plays a critical role in the detection and diagnosis of the disease.


Nephron Physiology | 2012

Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations.

Graciana Jaureguiberry; Muriel de La Dure-Molla; David A. Parry; Mickael Quentric; Nina Himmerkus; Toshiyasu Koike; James A. Poulter; Enriko Klootwijk; Steven L. Robinette; Alexander J. Howie; Vaksha Patel; Marie Lucile Figueres; Horia Stanescu; Naomi Issler; Jeremy K. Nicholson; Detlef Bockenhauer; Christopher Laing; Stephen B. Walsh; David A. McCredie; Sue Povey; Audrey Asselin; Arnaud Picard; Aurore Coulomb; Alan Medlar; Isabelle Bailleul-Forestier; Alain Verloes; Cedric Le Caignec; Gwenaelle Roussey; Julien Guiol; Bertrand Isidor

Background/Aims: Calcium homeostasis requires regulated cellular and interstitial systems interacting to modulate the activity and movement of this ion. Disruption of these systems in the kidney results in nephrocalcinosis and nephrolithiasis, important medical problems whose pathogenesis is incompletely understood. Methods: We investigated 25 patients from 16 families with unexplained nephrocalcinosis and characteristic dental defects (amelogenesis imperfecta, gingival hyperplasia, impaired tooth eruption). To identify the causative gene, we performed genome-wide linkage analysis, exome capture, next-generation sequencing, and Sanger sequencing. Results: All patients had bi-allelic FAM20A mutations segregating with the disease; 20 different mutations were identified. Conclusions: This au-tosomal recessive disorder, also known as enamel renal syndrome, of FAM20A causes nephrocalcinosis and amelogenesis imperfecta. We speculate that all individuals with biallelic FAM20A mutations will eventually show nephrocalcinosis.


Orphanet Journal of Rare Diseases | 2014

Pathognomonic oral profile of Enamel Renal Syndrome (ERS) caused by recessive FAM20A mutations.

Muriel de La Dure-Molla; Mickael Quentric; Paulo Marcio Yamaguti; Ana Carolina Acevedo; Alan J. Mighell; Miikka Vikkula; Mathilde Huckert; Ariane Berdal; Agnès Bloch-Zupan

Amelogenesis imperfecta (AI) is a genetically and clinically heterogeneous group of inherited dental enamel defects. Commonly described as an isolated trait, it may be observed concomitantly with other orodental and/or systemic features such as nephrocalcinosis in Enamel Renal Syndrome (ERS, MIM#204690), or gingival hyperplasia in Amelogenesis Imperfecta and Gingival Fibromatosis Syndrome (AIGFS, MIM#614253). Patients affected by ERS/AIGFS present a distinctive orodental phenotype consisting of generalized hypoplastic AI affecting both the primary and permanent dentition, delayed tooth eruption, pulp stones, hyperplastic dental follicles, and gingival hyperplasia with variable severity and calcified nodules. Renal exam reveals a nephrocalcinosis which is asymptomatic in children affected by ERS. FAM20A recessive mutations are responsible for both syndromes. We suggest that AIGFS and ERS are in fact descriptions of the same syndrome, but that the kidney phenotype has not always been investigated fully in AIGFS. The aim of this review is to highlight the distinctive and specific orodental features of patients with recessive mutations in FAM20A. We propose ERS to be the preferred term for all the phenotypes arising from recessive FAM20A mutations. A differential diagnosis has to be made with other forms of AI, isolated or syndromic, where only a subset of the clinical signs may be shared. When ERS is suspected, the patient should be assessed by a dentist, nephrologist and clinical geneticist. Confirmed cases require long-term follow-up. Management of the orodental aspects can be extremely challenging and requires the input of multi-disciplinary specialized dental team, especially when there are multiple unerupted teeth.


Journal of Dental Research | 2013

Homozygous and Compound Heterozygous MMP20 Mutations in Amelogenesis Imperfecta

Barbara Gasse; E. Karayigit; E. Mathieu; S. Jung; A. Garret; Mathilde Huckert; S. Morkmued; C. Schneider; L. Vidal; J. Hemmerlé; Jean-Yves Sire; Agnès Bloch-Zupan

In this article, we focus on hypomaturation autosomal-recessive-type amelogenesis imperfecta (type IIA2) and describe 2 new causal Matrix metalloproteinase 20 (MMP20) mutations validated in two unrelated families: a missense mutation p.T130I at the expected homozygous state, and a compound heterozygous mutation having the same mutation combined with a nucleotide deletion, leading to a premature stop codon (p.N120fz*2). We characterized the enamel structure of the latter case using scanning electron microscopy analysis and microanalysis (Energy-dispersive X-ray Spectroscopy, EDX) and confirmed the hypomaturation-type amelogenesis imperfecta as identified in the clinical diagnosis. The mineralized content was slightly decreased, with magnesium substituting for calcium in the crystal structure. The anomalies affected enamel with minimal inter-rod enamel present and apatite crystals perpendicular to the enamel prisms, suggesting a possible new role for MMP20 in enamel formation.


European Journal of Human Genetics | 2014

Clinical utility gene card for: Hypophosphatasia – update 2013

Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer

Update to: European Journal of Human Genetics (2010) 19; doi:10.1038/ejhg.2010.170; published online 27 October 2010


BMC Research Notes | 2013

Molars and incisors: show your microarray IDs

Virginie Laugel-Haushalter; Marie Paschaki; Christelle Thibault-Carpentier; Doulaye Dembélé; Pascal Dollé; Agnès Bloch-Zupan

BackgroundOne of the key questions in developmental biology is how, from a relatively small number of conserved signaling pathways, is it possible to generate organs displaying a wide range of shapes, tissue organization, and function. The dentition and its distinct specific tooth types represent a valuable system to address the issues of differential molecular signatures. To identify such signatures, we performed a comparative transcriptomic analysis of developing murine lower incisors, mandibular molars and maxillary molars at the developmental cap stage (E14.5).Results231 genes were identified as being differentially expressed between mandibular incisors and molars, with a fold change higher than 2 and a false discovery rate lower than 0.1, whereas only 96 genes were discovered as being differentially expressed between mandibular and maxillary molars. Numerous genes belonging to specific signaling pathways (the Hedgehog, Notch, Wnt, FGF, TGFβ/BMP, and retinoic acid pathways), and/or to the homeobox gene superfamily, were also uncovered when a less stringent fold change threshold was used. Differential expressions for 10 out of 12 (mandibular incisors versus molars) and 9 out of 10 selected genes were confirmed by quantitative reverse transcription-PCR (qRT-PCR). A bioinformatics tool (Ingenuity Pathway Analysis) used to analyze biological functions and pathways on the group of incisor versus molar differentially expressed genes revealed that 143 genes belonged to 9 networks with intermolecular connections. Networks with the highest significance scores were centered on the TNF/NFκB complex and the ERK1/2 kinases. Two networks ERK1/2 kinases and tretinoin were involved in differential molar morphogenesis.ConclusionThese data allowed us to build several regulatory networks that may distinguish incisor versus molar identity, and may be useful for further investigations of these tooth-specific ontogenetic programs. These programs may be dysregulated in transgenic animal models and related human diseases leading to dental anomalies.


Human Molecular Genetics | 2015

Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta

Mathilde Huckert; Corinne Stoetzel; Supawich Morkmued; Virginie Laugel-Haushalter; Véronique Geoffroy; Jean Muller; François Clauss; Megana K. Prasad; Frédéric Obry; Jean Louis Raymond; Marzena Switala; Yves Alembik; Sylvie Soskin; Eric Mathieu; Joseph Hemmerlé; Jean-Luc Weickert; Branka Dabovic; Daniel B. Rifkin; Annelies Dheedene; Eveline Boudin; Oana Caluseriu; Marie-Claude Cholette; Ross McLeod; Reynaldo Antequera; Marie-Paule Gellé; Jean-Louis Coeuriot; Louis-Frédéric Jacquelin; Isabelle Bailleul-Forestier; Marie-Cécile Manière; Wim Van Hul

Inherited dental malformations constitute a clinically and genetically heterogeneous group of disorders. Here, we report on four families, three of them consanguineous, with an identical phenotype, characterized by significant short stature with brachyolmia and hypoplastic amelogenesis imperfecta (AI) with almost absent enamel. This phenotype was first described in 1996 by Verloes et al. as an autosomal recessive form of brachyolmia associated with AI. Whole-exome sequencing resulted in the identification of recessive hypomorphic mutations including deletion, nonsense and splice mutations, in the LTBP3 gene, which is involved in the TGF-beta signaling pathway. We further investigated gene expression during mouse development and tooth formation. Differentiated ameloblasts synthesizing enamel matrix proteins and odontoblasts expressed the gene. Study of an available knockout mouse model showed that the mutant mice displayed very thin to absent enamel in both incisors and molars, hereby recapitulating the AI phenotype in the human disorder.


PLOS ONE | 2014

RSK2 Is a Modulator of Craniofacial Development

Virginie Laugel-Haushalter; Marie Paschaki; Pauline Marangoni; Coralie Pilgram; Arnaud Langer; Thibaut Kuntz; Julie Demassue; Supawich Morkmued; Philippe Choquet; André Constantinesco; Fabien Bornert; Matthieu Schmittbuhl; Solange Pannetier; Laurent Viriot; André Hanauer; Pascal Dollé; Agnès Bloch-Zupan

Background The RSK2 gene is responsible for Coffin-Lowry syndrome, an X-linked dominant genetic disorder causing mental retardation, skeletal growth delays, with craniofacial and digital abnormalities typically associated with this syndrome. Craniofacial and dental anomalies encountered in this rare disease have been poorly characterized. Methodology/Principal Findings We examined, using X-Ray microtomographic analysis, the variable craniofacial dysmorphism and dental anomalies present in Rsk2 knockout mice, a model of Coffin-Lowry syndrome, as well as in triple Rsk1,2,3 knockout mutants. We report Rsk mutation produces surpernumerary teeth midline/mesial to the first molar. This highly penetrant phenotype recapitulates more ancestral tooth structures lost with evolution. Most likely this leads to a reduction of the maxillary diastema. Abnormalities of molar shape were generally restricted to the mesial part of both upper and lower first molars (M1). Expression analysis of the four Rsk genes (Rsk1, 2, 3 and 4) was performed at various stages of odontogenesis in wild-type (WT) mice. Rsk2 is expressed in the mesenchymal, neural crest-derived compartment, correlating with proliferative areas of the developing teeth. This is consistent with RSK2 functioning in cell cycle control and growth regulation, functions potentially responsible for severe dental phenotypes. To uncover molecular pathways involved in the etiology of these defects, we performed a comparative transcriptomic (DNA microarray) analysis of mandibular wild-type versus Rsk2-/Y molars. We further demonstrated a misregulation of several critical genes, using a Rsk2 shRNA knock-down strategy in molar tooth germs cultured in vitro. Conclusions This study reveals RSK2 regulates craniofacial development including tooth development and patterning via novel transcriptional targets.


European Journal of Human Genetics | 2011

Clinical utility gene card for: hypophosphatasia.

Etienne Mornet; Christine R. Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer

1.5 Mutational spectrum Over 200 different disease-causing mutations have been reported in the ALPL gene mutations. Database: http://www.sesep.uvsq.fr/03_hypo_mutations.php. The distribution is as follows: 79% missense mutations; 10% small deletions; 4% splicing mutations; 3% nonsense mutations; 2% small insertions; and r1%: complex insertion/deletions, large deletions and mutations in the regulatory sequence. The large proportion of missense mutations with various effects on the enzymatic activity of alkaline phosphatase has been correlated with the high clinical variability.1 A part of missense mutations exhibits a dominant-negative effect,2–5 explaining dominant inheritance of mild forms of the disease.6–8

Collaboration


Dive into the Agnès Bloch-Zupan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean Muller

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vincent Laugel

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge